progesterone in the blood serum is found in the women of reproductive age. According to the literature, progesterone has a close relationship with T-cell immunity. A value of T-cell deficiency plays an important role in the cause of the autoimmune process Objectives: To study of progesterone correction in RA patients.The aim of this study was to evaluate the effectiveness of progesterone deficiency correction in patients with rheumatoid arthritis based on the analysis of articular syndrome Methods: The study involved 40 patients with a documented diagnosis of RA, women of reproductive age. The study group consisted of 30 patients who had correction of progesterone deficiency background in the pathogenetic therapy. The control group consisted of 10 female patients who are on the pathogenetic therapy. We used the following criteria: disease activity and severity of the articular syndrome with determining of the number of tender and swollen joints, indices of DAS and HAQ. Statistical analysis of the results of research used the method of parametrics of Student criterion Results: Among the patients studied disease duration ranged from 3 months to 19 years (mean age 10±7,2 years), 20 patients (50%), from 5 to 10 years -15 (37.5%), and more than 10 years -5 patients (12.5%). X-ray picture of joint damage in the majority of patients corresponded to stage 2-3 -87.5% (35 patients). Less common muscular disorders (7.5%), mainly in patients taking long-term GC, myalgia and muscle malnutrition were detected in 7.5% and 25% of patients, respectively. In addition to the articular syndrome, the most frequent complaints of general weakness (75%), irritability, sleep disorders and attention (50%), anxiety and anxiety (75%), low-grade temperature (10%) Conclusions: Progesterone deficiency correction in RA patients against pathogenic therapy has improved performance of articular syndrome and improves quality of life, such as vitality, general health and social function as well as it contributes to the positive dynamics of mental health References: [1] Background: Rheumatoid arthritis (RA) is a chronic disease that implies high direct and indirect costs for the health system (1,2). According to the needs of the health care system, the clinical interests and the national regulatory framework, it was developed a national registry information of RA patients (3) . Objectives: To show how a registry of information that would meet the RA situation was developed and to present the results obtained from the analysis of the Registry on this first year. Methods: A national RA Registry was created after a comprehensive literature review to identify the relevant variables to determine monitoring indicators used by health insurers and health services providers in the attention of patients with RA. Variables were selected and defined by an agreement with clinical experts, thematic and methodological experts and were evaluated by the Ministry of Health in order to review and approve the structure to gather the information. Results: A structure of 89 variables contained was defined. All entities must report annually to the Registry all the patients with a diagnosis of RA, their clinical and demographic characteristics, and the process of care and costs (3). On its first year the Registry provided a baseline of the disease situation of 68.357 patients with RA. Prevalence, incidence, state of disease and drugs including synthetic and biologic DMARDs were analyzed (Table 1) . Most important results were: mean age 57 years; relation women: men 5.2:1; age at onset of disease: 36 years, mean evolution time of disease: 7 years; population with DAS 28 measured 45.6%; mean DAS-28 2.8; percentage of the patient with DMARD therapy 78.9% and bDMARD 16.5%. Conclusions: A national Registry supported by an official policy, with data from the real world provided for healthcare insurers gives an opportunity to obtain a global vision and to identify failures and strengths in the attention process of RA, and to develop indicators to obtain better outcomes. In the future, through continuous efforts towards improving the quality of care provided, these will allow to monitoring and decreasing the burden of RA in the country and may serve as a model to other countries. One hundred and six patients with infectious spondylodicitis hospitalized in the department of rheumatology were analyzed. All patients were thoroughly interrogated subjected to a rigorous clinical examination and a battery of investigations including: complete blood count, urine analysis, blood culture, erythrocyte sedimentation rate, C -reactive protein (CRP) and serology for brucellosis. The imaging of spine ordered including: X-ray, bone scan and magnetic resonance imaging (MRI) with contrast enhancement. Results: Thirty of the 106 patients (28%) proved to have spinal brucellosis. The mean age of these patients was 53 years (range 15-68 years) and female/men ratio at 1.5. The mean delay of diagnosis was 8 months. The following symptoms were observed: fever in 14 patients and back pain in all of patients. Other symptoms were less frequently observed, such as splenomegaly (2 patients), peripheral adenopathy (5 patients) and diarrhea (2 patients). Laboratory exams showed elevated erythrocyte sedimentation rate in 13 patients, high levels of CRP in all patients and leukocytosis in 11 cases. Wright serology was positive in 21 of the patients. Brucella melitensis was isolated in blood cultures in 2 cases. Standard X-rays were performed in all patients. They showed signs of spondylodiscitis in the lumbar spine in 20 cases, cervical in 2 cases and dorsal in 8 cases. Ct-scan and MRI confirms the diagnosis and showed associated epiduritis in 2 cases or abscess in 6 cases. Bone biopsy with histopathological examination was performed in 7 cases. A combination of cycline and rifampicin was given to all patients. The duration of therapy was between 6 and 8 weeks. Conclusions: Brucellosis is present with various clinical signs in endemic areas and may simulate many diseases. The need for prompt diagnosis and treatment of spinal brucellosis is of utmost importance to prevent serious bone destruction and severe neurologic Sequelae. (3) . Common therapies for this include the administration of nitrate-rich medication. However, in the general population beetroot juice supplementation has been shown to increase NO bioavailability (4). It could therefore have beneficial effects on endothelial function of these patients as well.
HPR interventions (educational, physical, social and psychological)

AB1215-HPR EFFECTS OF BEETROOT JUICE SUPPLEMENTATION N ENDOTHELIAL FUNCTION AND MARKERS OF INFLAMMATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS
Objectives: To evaluate the effects of short-term beetroot juice supplementation on endothelial function in patients with RA and COPD. Methods: A total of 28 patients, 9 with RA, 9 with COPD and 10 healthy controls participated in the study. Following consent, they were asked to report at the testing venue (Ultrasonography Laboratory, General Hospital of Trikala) early in the morning, following an overnight fast. Demographic and disease characteristics were recorded; height, weight, classical risk factor for cardiovascular disease and body composition were assessed. Endothelial function was assessed using flow mediated vasodilatation. They randomly received either beetroot (experimental leg) or blackcurrant juice (control leg), which they consumed daily for two weeks. Thereafter they were re-evaluated. Following a two-week washout period, they crossed over to the other leg of the study.
Results: There was no difference in pre-occlusion diameter between any of the time-points. Endothelial function was significantly improved following beetroot juice consumption for both patient groups (RA: 2.6% [0. Background: Subacromial impingement syndrome (SIS) is defined as the mechanical compression of subacromial structures between the coraco-acromial arch and the humerus during active elevation of the arm above shoulder height. Objectives: The aim of the study was to investigate the effects of applications of iontophoresis and phonophoresis, which has been used in addition to physiotherapy program on pain and disability level in patients with SIS. Methods: The study was conducted with subjects (n=43) diagnosed with SIS. The subjects were divided into two groups randomly as iontophoresis group (IG) and phonophoresis group (PG). Diclofenac sodium iontophoresis was applied to the first group (n=22), diclofenac sodium phonophoresis was applied to the second group (n=21). In addition all of groups therapy program includes superficial heat, transcutaneous electrical nerve stimulation and exercise. The groups were evaluated before and after treatment in terms of pain and scores of shoulder disability. Visual analog scale was used to assess of pain (night pain, rest pain, pain with motion and pain in functional use), Shoulder Disability Questionnaire (SDQ) and Disabilities of the Arm Shoulder and Hand (DASH) were used to assess of shoulder disability. Results: 43 patients with IS aged 18 to 65 years were recruited to the study. Demographic data were similar in the groups. After treatments pain severity (night pain and pain in functional use) was significantly decreased in both groups (p<0,05) and in the scores of disability of shoulder (p<0,05) in both groups. Pain relief was similar in groups. SDQ and DASH scores were improved in two groups after treatments. But there was no difference between the groups in terms of functionality and disability scores.
AB1216-HPR THE EFFECTS OF APPLICATION OF IONTOPHORESIS AND PHONOPHORESIS IN PATIENTS WITH SUBACROMIAL IMPINGEMENT SYNDROME
Conclusions: This study shows that diclofenac sodium iontophoresis and phonophorosis that are used in patients with subacromial impingement syndrome have similar positive therapeutic effects on shoulder functions.
